Literature DB >> 21709589

Annual review of advances in non-small cell lung cancer research: a report for the year 2010.

Thomas E Stinchcombe1, Jeffery Bogart, Nirmal K Veeramachaneni, Robert Kratzke, Ramaswamy Govindan.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21709589     DOI： 10.1097/JTO.0b013e3182246413

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  3 in total

1.  Increased μ-opioid receptor expression in metastatic lung cancer.

Authors:  P A Singleton; T Mirzapoiazova; R Hasina; R Salgia; J Moss
Journal:  Br J Anaesth       Date:  2014-06-11       Impact factor: 9.166

2.  HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression.

Authors:  Tamara Mirzapoiazova; Nurbek Mambetsariev; Frances E Lennon; Bolot Mambetsariev; Joshua E Berlind; Ravi Salgia; Patrick A Singleton
Journal:  Front Oncol       Date:  2015-07-21       Impact factor: 6.244

3.  The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer.

Authors:  Frances E Lennon; Tamara Mirzapoiazova; Bolot Mambetsariev; Valeriy A Poroyko; Ravi Salgia; Jonathan Moss; Patrick A Singleton
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.